Embolization Coils Market to Record an Exponential CAGR by 2027


Aneurysm can be defined as a sac or bulge that develops in the artery owing to weaker vessel wall. An aneurysm in the brain could include the surrounding nerves and brain tissue, which results in neck pain, upper back pain, nausea, vomiting, nerve paralysis, and headache. Arteriovenous malformation is an abnormal connection between the arteries and veins which prevents circulation of oxygenated blood throughout the brain.

Embolization coils or coil embolization is a minimally invasive process employed for the treatment of aneurysm aiding in reducing the bleeding and closing off the sac. This is an endovascular procedure, wherein a steerable catheter is inserted into the blood stream and guided to the brain. Tiny coils, mesh stents, and glue are employed to promote clotting and closing off the aneurysm.

Significant product launches and strategic acquisitions are the strategies employed by the market players to increase presence in the global Embolization Coils Market. In 2018, BALT USA, LLC received the U.S. FDA 510 (k) clearance for its Optima Coil System.

In 2015, Medtronic acquired Covidien and enhanced its portfolio of embolization products with the addition of embolization coils, liquid embolics, and accessories. Similarly, Abbott acquired St. Jude Medical in 2016 that enabled it to strengthen its market position in the medical devices market.

Request to View Brochure of Report –

Technological advances, including the development of 3D embolization coils, embolization coils with integrated deployment mechanism, hydrocoil, and miniatured coil, contribute to the growth of the market. The embolization coils with integrated deployment mechanism reduce the procedural costs. In addition, the development of single click mechanical detachment handle technology would ease the process of placement of detachable coils contributing to the growth of the market.

Research studies have indicated that the long-term success rate of coiling in brain aneurysms is over 85%. Increase in success rates of endovascular coiling for the treatment of aneurysms has resulted in a paradigm shift from clipping to coiling. Availability of coils in a range of shapes and sizes enabling the optimum product selection for the embolization procedure and low cost makes coiling the preferred mode of embolization procedure.

Complications associated with the embolization coils are projected to hamper the growth of the global market. These complications include coil migration and occlusion of a non-target vessel. Coil migration results in stroke, pulmonary embolism, or myocardial infarction. Other complications of coil embolization include vessel rupture, perforation, and vessel dissection.

Comments